Data Protection
By entering and submitting your details you agree that future communications by Geriatric Medicine, GM2 and Age Care, in conjunction with Cegedim Dendrite (trading in its own name or as the
Medical Mailing Company or MMC), may be sent to you using your e-mail address.
In addition Cegedim Dendrite may, from time to time, use the information provided to assist responsible third parties to conduct direct and interactive marketing (whether by post, telephone or electronic means), to conduct market research and information verification, to produce databases of our customers' marketing activities and otherwise in connection with Cegedim Dendrite's legitimate business or as required by law.
Third parties to whom information may be disclosed include the Department of Health, the Medicines and Healthcare Products Regulatory Agency (MHRA), publishers of medical journals,
pharmaceutical companies, Internet and other commercial organisations concerned with the promotion, distribution and development of medical products and services and the dissemination
of important and sometimes vitally urgent information as well as other Cegedim Group entities and service suppliers. This may involve transfers of information to other countries, including
countries which may not offer the same level of protection for personal data as is available in the UK, although Cegedim Dendrite has taken security measures to control information within its
possession.
"Cegedim Group" means Dendrite Europe Limited, its parent company Cegedim S.A. and any entities, partnerships, fi rms or corporations that are affi liates or subsidiaries of Cegedim S.A.
details of which are available on request.
|
